JNS-cover.jpgJournal of Neurological Sciences

Vol 489 | 15 October 2026

Editorial Board

  • Published in issue: October 15, 2026, 126135
  • PDF

 

Editorials

When algorithms speak first: The public health risk of consumer AI in ALS diagnosis

Stéphane Mathis, Gwendal Le Masson


World brain day 2026: Brain health – Access for all

Tissa Wijeratne, David W. Dodick, Steven L. Lewis on behalf of the Trustees of the World Federation of Neurology

 

Review Articles

FcRn inhibitors in the treatment of CIDP

Alexander H. Morrison, Jeffrey A. Allen


Intra-arterial thrombolytics after endovascular thrombectomy for acute ischemic stroke: A network meta-analysis of RCTs

Mohamed Elfil, Abdallah Abbas, Haneen Sabet, ..., Gurmeen Kaur, Chirag D. Gandhi, Fawaz Al-Mufti

 

Basic Research Papers

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study

Gisle Berg Helland, Brian Enriquez, Mona K. Beyer, ..., Einar August Høgestøl, Guri Hagberg, Anne Hege Aamodt


Early use of low dose rituximab in anti acetylcholine receptor generalized myasthenia gravis in South Wales – A retrospective study

Rana Alnasser Alsukhni, Aseel Al-Ansari, Marguerite Hill


Long-term treatment with Eptinezumab in special treatment situations: Real world data

Berit Höfer, Klaus Koschatzky, Rainer Sabatowski, Thea Koch, Anna Klimova, Gudrun Gossrau


Trends in antiseizure medication use among women of childbearing age with epilepsy

Revital Gandelman-Marton, Jacques Theitler


Association of hypoxic burden with brain atrophy in Alzheimer's disease

Eleonora Rollo, Benedetta Tafuri, Ludovica Tamburrino, ..., Roberto De Blasi, Valentina Gnoni, Giancarlo Logroscino


Riboflavin therapy in complex I deficiency: Two new cases of leukoencephalopathy and a systematic literature review

Giulia Ferrera, Federica Invernizzi, Manuela Spagnolo, Eleonora Lamantea, Isabella Moroni, Anna Ardissone


Involuntary inspiratory sigh in multiple system atrophy: A clinical and cerebral blood flow study

Yuki Nakagawa, Atsuhiko Sugiyama, Yoshikazu Nakano, ..., Yoshitaka Yamanaka, Shoichi Ito, Masahiro Mori


Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability–weighted analysis

Matteo Foschi, Lucio D'Anna, Francesca Gabriele, ..., Alexandros Polymeris, Federico De Santis, Simona Sacco


Rituximab in AChR and MusK Myasthenia Gravis: long-term follow-up with different therapeutic protocols

C. Erra, D. Ricciardi, G. Abbadessa, ..., C. Vinciguerra, A. Fasolino, F. Habetswallner


Association between glucagon-like peptide-1 receptor agonist use and ischemic stroke severity

Huanwen Chen, Dhairya A. Lakhani, Sridhara S. Yaddanapudi, ..., Ajay Malhotra, Marco Colasurdo, Dheeraj Gandhi


The International Alliance on Brain Health (IABH): Bridging global efforts toward integrated brain and mental health plans and the promotion of local implementations

Claudio L.A. Bassetti, Christopher Chen, Steven L. Lewis, ..., Andrea Sylvia Winkler, Danuta Wasserman, Facundo Manes


Pathology of general proprioception in a canine disease model of amyotrophic lateral sclerosis

Brandie R. Morgan-Jack, Martin L. Katz, Grace R. Kick, ..., Kiara Delgado, Michael Makinen, Joan R. Coates


Lower atrial fibrillation detection in cryptogenic stroke patients with patent foramen ovale: Evidence from insertable cardiac monitoring

Naoya Yamazaki, Hajime Ikenouchi, Daisuke Ando, ..., Kohei Takikawa, Ryosuke Doijiri, Takahiko Kikuchi


Early antihypertensive therapy in acute ischemic stroke: A Meta-analysis of randomized controlled trials

Gabriela Argollo Fernandes, Lorrany Larisse Costa Rodrigues, Maria Eduarda Sulzbacher e Lima, Ahmad Alareed

 

Clinical Short Communication

Demonstrating clinical and radiological variability of adult-onset Alexander disease in three siblings

Aditi Varma-Doyle, Aidan Long, Simon Cronin, Loai Aker, Raymond Y. Huang, Nagagopal Venna

Letters to the Editor

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis

Maonan Guo, Haiping Liu, Jie Han


Letter to the editor: France-Ratcliffe M, et al. ‘Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS’ [Journal of the Neurological Sciences 488 (2026) 126007]

Archana Koul, A. Bhoomadevi


Mental health comorbidity and multiple sclerosis outcomes: Clarifying progression through longitudinal, imaging, and equity-focused markers

Isabella Andrea Bolaños Bermúdez, Valeria Noguera, Diego Andrés Barrios Castellar, Juan Carlos Mora


Comment on “the neuropsychiatric features of long COVID in older adults and the potential association with neuroinflammation: Preliminary observations in a small cohort”

Shuhan Yang, Lihua Xuan


Response to Comment on “Agreement between the simplified Edinburgh CT criteria and the Boston MRI criteria v2.0 for cerebral amyloid angiopathy diagnosis in lobar intracerebral haemorrhage from a population-based perspective. Dijon Stroke Registry”

Yannick Béjot


Comment on “Agreement between the simplified Edinburgh CT criteria and the Boston MRI criteria v2.0 for cerebral amyloid angiopathy diagnosis in lobar intracerebral haemorrhage from a population-based perspective. Dijon stroke registry”

Anugraha Sreeram, Malavika Pramod Nair, Shaun Nevil, S. Anton Charles


Reply to “Comments on sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis”

Satoru Fujiwara, Aravind Ganesh


Comments on “Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis”

Zili Du


Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform

Marcus Vinícius Magno Gonçalves, Pedro José Tomaselli, Wilson Marques Junior


Is hypocapnia a marker of injury severity rather than a therapeutic target after acute ischemic stroke?

Yanjun Ling, Jingyu Li


Response to letter regarding article “Suspected autoimmune cerebellar ataxia: Predictors of immunotherapy response and diagnosis reclassification to neurodegenerative disease”

Naoko Nakamura, Yuichiro Ii, Yoshinori Hirata, Hirofumi Matsuyama, Asako Tamura, Akihiro Shindo


Comment on “Suspected autoimmune cerebellar ataxia: Predictors of immunotherapy response and diagnosis reclassification to neurodegenerative disease”

Yongheng Li, Shan Zhang


A response to “Is hypocapnia a marker of injury severity rather than a therapeutic target after acute ischemic stroke?”

Lauren M. Walker, Ricardo C. Nogueira, Terrie Vasilopoulos, Ronney B. Panerai, Thompson G. Robinson, Jatinder S. Minhas


Mortality in facioscapulohumeral muscular dystrophy requires exclusion of mitochondrial and other neuromuscular differentials

Daniel Matovu


Interpreting plasma p-tau217 discordance in real-world memory clinics

Haoyang Hu


Comment on “Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission”

Tanishka Muraleedharan, Wajahat Bilal Mohammed, Shaun Nevil, S. Anton Charles


Comment on “Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission”

Feifei Dou, Xiaoguang Yuan, Shen Liu


Acute akinetic collapse in Parkinson's disease: The need for a non-parkinsonian comparator and clearer Nosological boundaries

Muhammad Aslam, Mahaweer Kumar


Comment on “Global, regional and national burden of Parkinson's disease, 1990–2021: Update from the GBD 2021 study”

C. Mahendran, K.R. Pandiyan, V. Ramnath, Fabiola M. Dhanraj


Author's response

Yuki Hagiwara, Yoshitaka Tomoda, Shunsuke Kobayashi